VOGX VOGENX INC
$17.34▼ -0.63%
Healthcare
Other
Volume 106.0K
Avg Volume (10D) 95.0K
Key Metrics & Fundamentals
Market Cap
$257.59M
P/E Ratio
–
Div Yield
0.00%
52W Range
12.95 - 38.41
% vs 50 MA
-29.98%
% vs 200 MA
–%
RSI-14
43.6
MACD Histogram
+0.4000
Beta (1Y vs SPY)
0.50
Free Cash Flow
$27,138
Gross Rev
$0
Gross Profit
$0
EBITDA
-$358,215
COGS
–
Operating Exp
$355,384
Operating Income
-$355,384
EBIT
-$355,384
Pretax Income
-$384,430
Net Income
-$384,430
EPS (Diluted)
-0.03
Price & Volume History
Loading chart…
Recent News
Top Premarket Gainers
MT Newswires · Oct 22, 2026 7:10 AM ET
Vogenx Begins Phase 2b Trial of Mizagliflozin for Post-Bariatric Hypoglycemia
MT Newswires · Oct 15, 2026 5:18 PM ET
Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia
ACCESS Newswire · Oct 15, 2026 4:35 PM ET
Vogenx Appoints Richard Gorman Chief Commercial Officer
MT Newswires · Oct 9, 2026 9:02 AM ET
Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer
ACCESS Newswire · Oct 9, 2026 8:00 AM ET
Vogenx Appoints Ken Toombs to Board of Directors
ACCESS Newswire · Sep 22, 2026 9:00 AM ET
Federal Filings Joins Client Vogenx at the Nasdaq Opening Bell
GlobeNewswire · Aug 24, 2026 7:00 PM ET
Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering
PR Newswire · Aug 17, 2026 12:25 PM ET
Vogenx Announces Closing of Initial Public Offering
ACCESS Newswire · Aug 13, 2026 4:35 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See VOGX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.